Skip to main content

Avtozma 20 mg/mL injection (multiple presentations) Images

Generic Name: tocilizumab

This medication has been identified as Avtozma 20 mg/mL injection (multiple presentations). It is supplied by Celltrion USA.

Avtozma is used in the treatment of Giant Cell Arteritis; Rheumatoid Arthritis; COVID-19; Juvenile Idiopathic Arthritis; Polyarticular Juvenile Idiopathic Arthritis and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Avtozma 20 mg/mL injection (multiple presentations) is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Avtozma 20 mg/mL injection (multiple presentations) medicine

Avtozma

Generic Name
tocilizumab
Strength
20 mg/mL injection (multiple presentations)
Availability
Prescription only
Drug Class
Interleukin inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Celltrion USA
National Drug Code (NDC)
multiple

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.